324 related articles for article (PubMed ID: 21063035)
1. Role of central nervous system insulin resistance in fetal alcohol spectrum disorders.
de la Monte SM; Wands JR
J Popul Ther Clin Pharmacol; 2010; 17(3):e390-404. PubMed ID: 21063035
[TBL] [Abstract][Full Text] [Related]
2. Chronic ethanol exposure causes mitochondrial dysfunction and oxidative stress in immature central nervous system neurons.
Chu J; Tong M; de la Monte SM
Acta Neuropathol; 2007 Jun; 113(6):659-73. PubMed ID: 17431646
[TBL] [Abstract][Full Text] [Related]
3. Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration.
de la Monte SM; Tong M; Carlson RI; Carter JJ; Longato L; Silbermann E; Wands JR
Alcohol; 2009 May; 43(3):225-40. PubMed ID: 19393862
[TBL] [Abstract][Full Text] [Related]
4. Insulin and insulin-like growth factor resistance with neurodegeneration in an adult chronic ethanol exposure model.
Cohen AC; Tong M; Wands JR; de la Monte SM
Alcohol Clin Exp Res; 2007 Sep; 31(9):1558-73. PubMed ID: 17645580
[TBL] [Abstract][Full Text] [Related]
5. Ethanol-induced oxidative stress and mitochondrial dysfunction in rat placenta: relevance to pregnancy loss.
Gundogan F; Elwood G; Mark P; Feijoo A; Longato L; Tong M; de la Monte SM
Alcohol Clin Exp Res; 2010 Mar; 34(3):415-23. PubMed ID: 20028358
[TBL] [Abstract][Full Text] [Related]
6. Alcohol exposure during development: Impact on the epigenome.
Perkins A; Lehmann C; Lawrence RC; Kelly SJ
Int J Dev Neurosci; 2013 Oct; 31(6):391-7. PubMed ID: 23542005
[TBL] [Abstract][Full Text] [Related]
7. L1 coupling to ankyrin and the spectrin-actin cytoskeleton modulates ethanol inhibition of L1 adhesion and ethanol teratogenesis.
Dou X; Menkari C; Mitsuyama R; Foroud T; Wetherill L; Hammond P; Suttie M; Chen X; Chen SY; Charness ME;
FASEB J; 2018 Mar; 32(3):1364-1374. PubMed ID: 29109170
[TBL] [Abstract][Full Text] [Related]
8. Chronic gestational exposure to ethanol impairs insulin-stimulated survival and mitochondrial function in cerebellar neurons.
de la Monte SM; Wands JR
Cell Mol Life Sci; 2002 May; 59(5):882-93. PubMed ID: 12088287
[TBL] [Abstract][Full Text] [Related]
9. A review of interventions against fetal alcohol spectrum disorder targeting oxidative stress.
Zhang Y; Wang H; Li Y; Peng Y
Int J Dev Neurosci; 2018 Dec; 71():140-145. PubMed ID: 30205148
[TBL] [Abstract][Full Text] [Related]
10. Maternal oral intake mouse model for fetal alcohol spectrum disorders: ocular defects as a measure of effect.
Parnell SE; Dehart DB; Wills TA; Chen SY; Hodge CW; Besheer J; Waage-Baudet HG; Charness ME; Sulik KK
Alcohol Clin Exp Res; 2006 Oct; 30(10):1791-8. PubMed ID: 17010146
[TBL] [Abstract][Full Text] [Related]
11. TLR4 response mediates ethanol-induced neurodevelopment alterations in a model of fetal alcohol spectrum disorders.
Pascual M; Montesinos J; Montagud-Romero S; Forteza J; Rodríguez-Arias M; Miñarro J; Guerri C
J Neuroinflammation; 2017 Jul; 14(1):145. PubMed ID: 28738878
[TBL] [Abstract][Full Text] [Related]
12. PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair.
Pang M; de la Monte SM; Longato L; Tong M; He J; Chaudhry R; Duan K; Ouh J; Wands JR
J Hepatol; 2009 Jun; 50(6):1192-201. PubMed ID: 19398227
[TBL] [Abstract][Full Text] [Related]
13. Fetal alcohol spectrum disorders and abnormal neuronal plasticity.
Medina AE
Neuroscientist; 2011 Jun; 17(3):274-87. PubMed ID: 21383101
[TBL] [Abstract][Full Text] [Related]
14. GSK3beta in ethanol neurotoxicity.
Luo J
Mol Neurobiol; 2009 Oct; 40(2):108-21. PubMed ID: 19507062
[TBL] [Abstract][Full Text] [Related]
15. The preventive effect of oral EGCG in a fetal alcohol spectrum disorder mouse model.
Long L; Li Y; Wang YD; He QY; Li M; Cai XD; Peng K; Li XP; Xie D; Wen YL; Yin DL; Peng Y
Alcohol Clin Exp Res; 2010 Nov; 34(11):1929-36. PubMed ID: 20659071
[TBL] [Abstract][Full Text] [Related]
16. Proceedings of the 2010 annual meeting of the Fetal Alcohol Spectrum Disorders Study Group.
Kane CJ; Smith SM; Miranda RC; Kable J
Alcohol; 2012 Feb; 46(1):107-14. PubMed ID: 21889288
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide Inhibits Ethanol-Induced Caspase-3 and PARP-1 Over-activation and Subsequent Neurodegeneration in the Developing Mouse Cerebellum.
Ieraci A; Herrera DG
Cerebellum; 2018 Jun; 17(3):326-335. PubMed ID: 29327278
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of astaxanthin on fetal alcohol spectrum disorder in mice.
Zheng D; Li Y; He L; Tang Y; Li X; Shen Q; Yin D; Peng Y
Neuropharmacology; 2014 Sep; 84():13-8. PubMed ID: 24780381
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammatory contribution of microglia and astrocytes in fetal alcohol spectrum disorders.
Kane CJM; Drew PD
J Neurosci Res; 2021 Aug; 99(8):1973-1985. PubMed ID: 32959429
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and mitotic changes associated with the fetal alcohol syndrome.
Shibley IA; Pennington SN
Alcohol Alcohol; 1997; 32(4):423-34. PubMed ID: 9269850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
